Learn More
3-Bromoimidazo[1,2-a]pyridine-7-carboxylate de méthyle,95 %, Thermo Scientific Chemicals
76.95€ - 121.61€
Identifiants chimiques
CAS | 342613-63-2 |
---|---|
Formule moléculaire | C9H7BrN2O2 |
Poids moléculaire (g/mol) | 255.071 |
Numéro MDL | MFCD10566741 |
Clé InChI | VFFFBWRUZMAHFS-UHFFFAOYSA-N |
Synonyme | methyl 3-bromoimidazo 1,2-a pyridine-7-carboxylate, 3-bromo-7-methoxycarbonyl imidazo 1,2-a pyridine, methyl 3-bromoh-imidazo 1,2-a pyridine-7-carboxylate, 3-bromoimidazo 1,2-a pyridine-7-carboxylic acid methyl ester, pubchem23890, methyl3-bromoimidazo 1,2-a pyridine-7-carboxylate, 3-bromo-imidazo 1,2-a pyridine-7-carboxylic acid methyl ester, methyl 3-bromo-5h-imidazo 2,1-b 1,3 oxazine-7-carboxylate, 3-bromo-imidazo 1,2-alpha pyridine-7-carboxylic acid methyl ester, 3-bromoimidazo 1,2-alpha pyridine-7-carboxylic acid methyl ester |
CID PubChem | 45790121 |
Nom IUPAC | méthyle 3-bromoimidazo[1,2-a]pyridine-7-carboxylate |
SMILES | COC(=O)C1=CC2=NC=C(N2C=C1)Br |
Code produit | Marque | Quantité | Prix | Quantité et disponibilité | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Code produit | Marque | Quantité | Prix | Quantité et disponibilité | ||||||
15439065
|
Thermo Scientific Alfa Aesar
H35994.MD |
250 mg | N/A | N/A | N/A | |||||
15429065
|
Thermo Scientific Alfa Aesar
H35994.03 |
1 g |
121.61€
1g |
Veuillez vous connecter pour pouvoir commander cet article. Besoin d'un compte web? Créer le vôtre dès maintenant! | ||||||
Description
Methyl 3-bromoimidazo[1,2-a]pyridine-7-carboxylate is used as pharmaceutical intermediate.
This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.
ApplicationsLe méthyl3-bromoimidazo[1,2-a]pyridine-7-carboxylate est utilisé comme intermédiaire pharmaceutique.
Remarques
Stable dans les conditions de stockage recommandées. Incompatible avec les agents oxydants.
Identifiants chimiques
342613-63-2 | |
255.071 | |
VFFFBWRUZMAHFS-UHFFFAOYSA-N | |
45790121 | |
COC(=O)C1=CC2=NC=C(N2C=C1)Br |
C9H7BrN2O2 | |
MFCD10566741 | |
methyl 3-bromoimidazo 1,2-a pyridine-7-carboxylate, 3-bromo-7-methoxycarbonyl imidazo 1,2-a pyridine, methyl 3-bromoh-imidazo 1,2-a pyridine-7-carboxylate, 3-bromoimidazo 1,2-a pyridine-7-carboxylic acid methyl ester, pubchem23890, methyl3-bromoimidazo 1,2-a pyridine-7-carboxylate, 3-bromo-imidazo 1,2-a pyridine-7-carboxylic acid methyl ester, methyl 3-bromo-5h-imidazo 2,1-b 1,3 oxazine-7-carboxylate, 3-bromo-imidazo 1,2-alpha pyridine-7-carboxylic acid methyl ester, 3-bromoimidazo 1,2-alpha pyridine-7-carboxylic acid methyl ester | |
méthyle 3-bromoimidazo[1,2-a]pyridine-7-carboxylate |
Spécification
Methyl 3-bromoimidazo[1,2-a]pyridine-7-carboxylate | |
156°C to 157°C | |
MFCD10566741 | |
VFFFBWRUZMAHFS-UHFFFAOYSA-N | |
méthyle 3-bromoimidazo[1,2-a]pyridine-7-carboxylate | |
45790121 | |
95% |
342613-63-2 | |
C9H7BrN2O2 | |
methyl 3-bromoimidazo 1,2-a pyridine-7-carboxylate, 3-bromo-7-methoxycarbonyl imidazo 1,2-a pyridine, methyl 3-bromoh-imidazo 1,2-a pyridine-7-carboxylate, 3-bromoimidazo 1,2-a pyridine-7-carboxylic acid methyl ester, pubchem23890, methyl3-bromoimidazo 1,2-a pyridine-7-carboxylate, 3-bromo-imidazo 1,2-a pyridine-7-carboxylic acid methyl ester, methyl 3-bromo-5h-imidazo 2,1-b 1,3 oxazine-7-carboxylate, 3-bromo-imidazo 1,2-alpha pyridine-7-carboxylic acid methyl ester, 3-bromoimidazo 1,2-alpha pyridine-7-carboxylic acid methyl ester | |
COC(=O)C1=CC2=NC=C(N2C=C1)Br | |
255.071 | |
255.07 |
Sécurité et traitement
GHS H Statement
H315-H319-H335
Causes skin irritation.
Causes serious eye irritation.
May cause respiratory irritation.
P261-P264b-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P362-P501c
H315-H319-H335
missing translation for 'tsca' : No
Recommended Storage : Température ambiante
RUO – Research Use Only
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.